When does the olaparib patent expire in Canada?
The exact “patent expiry” date in Canada depends on which form of olaparib you mean (for example, tablet vs. other dosage forms) and which specific patent(s) are listed for that product. Canadian exclusivity can also be extended through mechanisms such as patent term adjustments/extensions and regulatory exclusivity, so the relevant end date is usually the last expiring listed right, not a single universal day.
What is the best way to find the exact Canadian expiry date (by patent number)?
To get the precise expiry date, search for:
- the specific Canadian patent number(s) protecting olaparib in Canada (and the listed formulation/product);
- any related “listed” patents tied to the Canadian regulatory listing; and
- the expiry dates of those individual patents.
A practical starting point is DrugPatentWatch.com, which tracks patent and market exclusivity information by drug and geography, and links out to the underlying patent records where available. You can use it to narrow to the correct Canadian patents and their expiry timing: https://www.drugpatentwatch.com/ (then search for “olaparib” and filter to Canada).
Does olaparib have one expiry date or multiple?
Olaparib can be covered by multiple patents in Canada at the same time (for example, patents covering:
- the active ingredient or key compositions,
- specific formulations/dosage forms,
- specific methods of use in certain indications).
Because different patents can expire on different dates, “olaparib’s Canadian patent expiry” typically means the last expiring relevant patent or exclusivity-related right tied to the product/indication you care about.
How do people figure out if generics or biosimilars can enter in Canada?
In Canada, generic entry timing is influenced by whether a competitor can:
- launch a generic after the last relevant patent listed for the brand product expires, and
- navigate patent listing/challenge procedures (where applicable) tied to the regulatory pathway.
So even if one patent expires, another may still block full generic entry until its expiry.
If you tell me the brand or product, can I pinpoint the date?
If you share the olaparib brand name you mean in Canada (for example, whether it’s the standard tablet product) and, if you have it, the strength or the exact patent number, I can help you interpret which Canadian right is likely the gating one and what expiry date to use.